On September 1, 2020 Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") reported that the Company’s Board of Directors has implemented its previously disclosed succession plan and appointed Rainer M. Blair as President and Chief Executive Officer and a member of the Board of Directors effective today, September 1, 2020 (Press release, Danaher, SEP 1, 2020, View Source [SID1234564253]). Mr. Blair’s predecessor, Thomas P. Joyce, Jr., retired from these positions and will continue to support Danaher as a senior advisor through February 28, 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!